These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8890756)

  • 81. [Clinical Value of Left Ventricular Hypertrophy in Arterial Hypertension].
    Kosiolova NA; Shatunova IM
    Kardiologiia; 2015; 55(8):62-7. PubMed ID: 26761975
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients.
    Bang CN; Gerdts E; Aurigemma GP; Boman K; de Simone G; Dahlöf B; Køber L; Wachtell K; Devereux RB
    Circ Cardiovasc Imaging; 2014 May; 7(3):422-9. PubMed ID: 24723582
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Effects of spironolactone during an angiotensin II receptor blocker treatment on the left ventricular mass reduction in hypertensive patients with concentric left ventricular hypertrophy.
    Taniguchi I; Kawai M; Date T; Yoshida S; Seki S; Taniguchi M; Shimizu M; Mochizuki S
    Circ J; 2006 Aug; 70(8):995-1000. PubMed ID: 16864931
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Effects of angiotensin II receptor blockade-based therapy with losartan on left ventricular hypertrophy and geometry in previously treated hypertensive patients.
    Cuspidi C; Meani S; Valerio C; Fusi V; Sala C; Maisaidi M; Zanchetti A
    Blood Press; 2006; 15(2):107-15. PubMed ID: 16754274
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Arrhythmogenicity in left ventricular hypertrophy in mild to moderate arterial hypertension].
    Franchi F; Michelucci A; Padeletti L; Monopoli A; Fabbri G; Cersosimo RM; Mezzani A
    G Ital Cardiol; 1992 Aug; 22(8):905-18. PubMed ID: 1478391
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Left ventricular hypertrophy in mild essential hypertension. Its progression, prediction and treatment strategy.
    Doba N; Tomiyama H; Yoshida H; Kihara Y; Watanabe G; Hinohara S
    Jpn Heart J; 1996 Jul; 37(4):417-29. PubMed ID: 8890756
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Studies on left ventricular hypertrophy regression in arterial hypertension: a clear message for the clinician?
    Cuspidi C; Esposito A; Negri F; Sala C; Masaidi M; Giudici V; Zanchetti A; Mancia G
    Am J Hypertens; 2008 Apr; 21(4):458-63. PubMed ID: 18369363
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The importance of left ventricular hypertrophy in human hypertension.
    Kahan T
    J Hypertens Suppl; 1998 Sep; 16(7):S23-9. PubMed ID: 9855028
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Current Perspectives on Left Ventricular Geometry in Systemic Hypertension.
    Oktay AA; Lavie CJ; Milani RV; Ventura HO; Gilliland YE; Shah S; Cash ME
    Prog Cardiovasc Dis; 2016; 59(3):235-246. PubMed ID: 27614172
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Left ventricular hypertrophy and hypertension.
    Devereux RB; de Simone G; Ganau A; Koren MJ; Mensah GA; Roman MJ
    Clin Exp Hypertens; 1993 Nov; 15(6):1025-32. PubMed ID: 8268870
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Ventricular hypertrophy and hypertension: prognostic elements and implications for management.
    Krauser DG; Devereux RB
    Herz; 2006 Jun; 31(4):305-16. PubMed ID: 16810470
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Changes in left ventricular geometry during antihypertensive treatment.
    Salvetti M; Paini A; Bertacchini F; Stassaldi D; Aggiusti C; Agabiti Rosei C; Bassetti D; Agabiti-Rosei E; Muiesan ML
    Pharmacol Res; 2018 Aug; 134():193-199. PubMed ID: 29959031
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Assessment of prevalence of left ventricular hypertrophy in hypertension.
    Korner PI; Jennings GL
    J Hypertens; 1998 Jun; 16(6):715-23. PubMed ID: 9663910
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Hypertrophy to failure.
    Tanser PH
    J Hum Hypertens; 1994 Sep; 8 Suppl 1():S17-20. PubMed ID: 7807508
    [TBL] [Abstract][Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.